Safety and Efficacy Study of OPC-415 in Patients With Relapsed and/or Refractory Multiple Myeloma
Clinical trial NCT04649073 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04649073
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-18
- Primary completion
- 2025-04-09
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.